Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Broad betacoronavirus neutralization by a stem helix–specific human antibody
Dora Pinto, Maximilian M. Sauer, Nadine Czudnochowski, et al.
Science (2021) Vol. 373, Iss. 6559, pp. 1109-1116
Open Access | Times Cited: 351

Showing 26-50 of 351 citing articles:

Neutralization mechanism of a human antibody with pan-coronavirus reactivity including SARS-CoV-2
Xiaoyu Sun, Chunyan Yi, Yuanfei Zhu, et al.
Nature Microbiology (2022) Vol. 7, Iss. 7, pp. 1063-1074
Open Access | Times Cited: 111
Antibody-dependent cellular cytotoxicity response to SARS-CoV-2 in COVID-19 patients
Yuanling Yu, Meiyu Wang, Xiao‐Ai Zhang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 101
mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concern
Paulina Kapłonek, Stephanie Fischinger, Deniz Cizmeci, et al.
Immunity (2022) Vol. 55, Iss. 2, pp. 355-365.e4
Open Access | Times Cited: 100
Close relatives of MERS-CoV in bats use ACE2 as their functional receptors
Qing Xiong, Lei Cao, Chengbao Ma, et al.
Nature (2022) Vol. 612, Iss. 7941, pp. 748-757
Open Access | Times Cited: 100
Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice
Andrew C. Hunt, James Brett Case, Young‐Jun Park, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 646
Open Access | Times Cited: 97
A large-scale systematic survey reveals recurring molecular features of public antibody responses to SARS-CoV-2
Yiquan Wang, Meng Yuan, Huibin Lv, et al.
Immunity (2022) Vol. 55, Iss. 6, pp. 1105-1117.e4
Open Access | Times Cited: 85
SARS-CoV-2 S2–targeted vaccination elicits broadly neutralizing antibodies
Kevin W. Ng, Nikhil Faulkner, Katja Finsterbusch, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 655
Open Access | Times Cited: 85
Stopping pandemics before they start: Lessons learned from SARS-CoV-2
A.M. Edwards, Ralph S. Baric, Erica Ollmann Saphire, et al.
Science (2022) Vol. 375, Iss. 6585, pp. 1133-1139
Open Access | Times Cited: 82
Broad anti–SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1/mRNA-1273 vaccination
Chengzi I. Kaku, Elizabeth Champney, Johan Normark, et al.
Science (2022) Vol. 375, Iss. 6584, pp. 1041-1047
Open Access | Times Cited: 71
SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines
John E. Bowen, Young‐Jun Park, Cameron Stewart, et al.
Science Immunology (2022) Vol. 7, Iss. 78
Open Access | Times Cited: 70
Potential Autoimmunity Resulting from Molecular Mimicry between SARS-CoV-2 Spike and Human Proteins
Janelle Nunez-Castilla, Vitalii Stebliankin, Prabin Baral, et al.
Viruses (2022) Vol. 14, Iss. 7, pp. 1415-1415
Open Access | Times Cited: 68
Identification of a conserved S2 epitope present on spike proteins from all highly pathogenic coronaviruses
Rui P. Silva, Yimin Huang, Annalee W. Nguyen, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 64
Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein
Filippo Bianchini, Virginia Crivelli, Morgan E. Abernathy, et al.
Science Immunology (2023) Vol. 8, Iss. 81
Open Access | Times Cited: 58
Persistent immune imprinting occurs after vaccination with the COVID-19 XBB.1.5 mRNA booster in humans
M. Alejandra Tortorici, Amin Addetia, Albert J. Seo, et al.
Immunity (2024) Vol. 57, Iss. 4, pp. 904-911.e4
Open Access | Times Cited: 54
Targetable elements in SARS-CoV-2 S2 subunit for the design of pan-coronavirus fusion inhibitors and vaccines
Liyan Guo, Sheng Lin, Zimin Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 44
Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccines
Chieh-Yu Liang, Saravanan Raju, Zhuoming Liu, et al.
Nature (2024) Vol. 630, Iss. 8018, pp. 950-960
Closed Access | Times Cited: 29
Human coronavirus OC43-elicited CD4+ T cells protect against SARS-CoV-2 in HLA transgenic mice
Rúbens Prince dos Santos Alves, Julia Timis, Robyn Miller, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Multiple independent acquisitions of ACE2 usage in MERS-related coronaviruses
Chengbao Ma, Chen Liu, Young‐Jun Park, et al.
Cell (2025)
Open Access | Times Cited: 3
Molecular basis of convergent evolution of ACE2 receptor utilization among HKU5 coronaviruses
Young‐Jun Park, Chen Liu, Jimin Lee, et al.
Cell (2025)
Closed Access | Times Cited: 3
Bat-infecting merbecovirus HKU5-CoV lineage 2 can use human ACE2 as a cell entry receptor
Jing Chen, Wei Zhang, Yang Li, et al.
Cell (2025)
Closed Access | Times Cited: 1
Stabilized coronavirus spike stem elicits a broadly protective antibody
Ching‐Lin Hsieh, Anne P. Werner, Sarah R. Leist, et al.
Cell Reports (2021) Vol. 37, Iss. 5, pp. 109929-109929
Open Access | Times Cited: 82
Structure, receptor recognition, and antigenicity of the human coronavirus CCoV-HuPn-2018 spike glycoprotein
M. Alejandra Tortorici, Alexandra C. Walls, Anshu Joshi, et al.
Cell (2022) Vol. 185, Iss. 13, pp. 2279-2291.e17
Open Access | Times Cited: 58
Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like viruses
Wanting He, Rami Musharrafieh, Ge Song, et al.
Nature Immunology (2022) Vol. 23, Iss. 6, pp. 960-970
Open Access | Times Cited: 56
Challenges and developments in universal vaccine design against SARS-CoV-2 variants
Fangxin Zhao, Xiaodong Zai, Zhiling Zhang, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 56
Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2
Cyril Planchais, I. Fernández, Timothée Bruel, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 7
Open Access | Times Cited: 51

Scroll to top